References
- Polansky JR. Side-effects of topical therapy with anti-inflammatory steroids. Curr Opin Ophthalmol 1992;3:259–272.
- Goa LK, Chrisp P. Ocular diclofenac. A review of its pharmacology and clinical use in cataract surgery, and potential in other inflammatory ocular conditions. Drugs Ageing 1992;2:473–486.
- Rowsey JJ. Anti-infective agents. In: Bartlett JD, Ghormley NR, Jaanus SD, Rowsey JJ, Zimmermann TJ, editors. Ophthalmic Drug Facts. St. Louis, MO, USA: Kluwer, 1994; 98.
- Everett SL, Kowalski RP, Karenchak LM, Landsittel D, Day R, Gordon YJ. An in vitro comparison of the susceptibilities of bacteria isolated from patients with conjunctivitis and blepharitis to newer and established topical antibiotics. Cornea 1995;14:382–387.
- Suharwardy H, Long C, Bell J, Munton CGF. A comparative trial between diclofenac-gentamicin and betamethasone-neomycin drops in patients undergoing cataract extraction. Eye 1994;8:550–554.
- Stern GA, Killingsworth DW. Complications of topical antimicrobial agents. Int Ophthalmol Clin 1989;29:137–142.
- Leaming DV. Practice styles and preferences of ASCRS members-1995 survey. J Cataract Refract Surg 1996;22:931–939.
- Courtney P. The national cataract surgery survey. I. Method and descriptive features. Eye 1992;6:487–492.